FAS and ovarian cancer: FAS is upregulated and associated with malignant progression in cancer: inhibition of FAS reduced invasion and migration of HCC [120], and was found responsible of promoting peritoneal metastasis in ovarian cancer through induction of epithelial to mesenchymal transition (EMT) [121].